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a b s t r a c t
Pulmonarymucormycosis is a very rare clinical condition in patientswithout underlying risk
factors. A limited number of cases have been reported in predominantly elderly patients;
history of smoking appears to be a common feature. A case of non-smoking male who
developed pulmonary mucormycosis with the longest reported follow-up is presented. InKeywords:
Pulmonary mucormycosis
Predisposing risk factor
addition, this is also the ﬁrst reported case with disease recurrence after lobectomy (two
years) in an immunocompetent host. Treatment with an additional lobectomy and ampho-
tericin B was successful in this patient.
© 2012 Elsevier Editora Ltda. Este é um artigo Open Access sob a licença de CC BY-NC-NDIntroduction
Mucormycosis (also termed as zygomycosis) is an opportunis-
tic infection caused by fungi from the order of Mucorales,
which are quite common in the environment. Clinical infec-
tions caused by such fungi usually occur in the presence of
predisposing risk factors, such as diabetes mellitus, hemato-
logic malignancies, hematopoietic stem cell transplantation,
deferoxamine therapy, HIV infection, iron overload, trauma
or burns, and use of corticosteroids or immunosuppress-
ive drugs.1,2 Mucormycosis in patients without underlying
conditions is rare, and when it occurs, it is likely to be a super-
2ﬁcial infection. Pulmonary mucormycosis in such patients is
exceedingly rare. To the best of the authors’ knowledge, only
ten cases have been previously reported3–12 in the literature,
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Este é um artigo Open Access sob a licençaand most were elderly male smokers. Herein is reported a
case of a non-smoking young male who was 12 years old at
the onset of the disease. With the longest follow-up known
in literature, this is also the ﬁrst reported case of an immuno-
competent patientwho suffered fromdisease recurrence after
surgical treatment. Meanwhile, this is also the ﬁrst such case
reported in China, the most populous country in the world.
Case presentation
In August, 2008, a 14-year-old boy was referred to this hospital
with a two-month history of fever, cough, purulent sputum,g Union Medical College Hospital, Chinese Academy of Medical
and nasal discharge. Two years earlier, he had undergone a
lobectomy of right inferior lobe at a local hospital due to fever
and pulmonary mass in the right lung, with a post-operative
 de CC BY-NC-ND
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Fig. 1 – (A) Chest CT scan showed a mass in lower lobe of the left lung. (B) Broad, irregularly branched and non-septate
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ryphae with positive methenamine silver stain observed in
athological diagnosis of ‘inﬂammatory pseudotumor’. After
he surgery, he was doing well until two months before this
dmission. He was an otherwise healthy boy with no his-
ory of diabetes mellitus, hematologic malignancies, burns or
rauma, intravenous drug use, malnutrition or diarrhea, renal
ailure, or use of corticosteroids or immunosuppressive drugs
r deferoxamine. He lived in a small village in the Shandong
rovince of China, with both parents working as corn farm-
rs. The boy sometimes helped with farming as well. He was
non-smoker and had never consumed alcohol.
On examination, the patient was febrile with a temper-
ture of 38 ◦C and normotensive. Purulent nasal discharges
ssociated with sinus pain were noted. Breath sounds were
ow in both lower lungs with crackles heard on the left side.
aboratory investigation showed the following results (normal
eference range in parenthesis): hemoglobin 12.1 (11.0-16.0)
/dL; white blood cell count, 9.5× 109 (4.0-10.0× 109) cells/L;
aised erythrocyte sedimentation rate of 53 (< 20) mm/h and
levated C-reactive protein level of 91.4 (< 3)mg/L; serumurea,
.5 (2.5-6.5) mmol/L; creatinine, 64 (60-110) mol/L; sodium,
36 (135-145) mmol/L; and potassium 4.0 (3.5-5.5) mmol/L.
iver function tests were normal: total proteins, 71 (60-85)
/L, alanine transaminase (ALT), 11 (10-40) IU/L; aspartate
ransaminase (AST), 21 (8-40) IU/L; albumin, 40 (35-55) g/L; and
lkaline phosphatase (ALP) 60 (44-147) IU/L. Serum protein
lectrophoresis showed elevated gammaglobulins. A 75g oral
lucose tolerance test was normal. HIV serology was negative.
esults of serum iron studies were all within normal range:
erum iron concentration, 84 (60-150) microg/dL; plasma total
ron binding capacity, 288 (200-400) microg/dL; transferring
aturation, 29 (25-35)%; serum ferritin concentration, 46 (14-
36) ng/mL. Sputum cultures were negative for bacteria or
ungi. Sinus computed tomography (CT) scan revealed a dense
nd non-homogeneous mass and sinusitis in the left max-
lla, and chest CT showed a mass with a diameter of 3 cm in
he left inferior lobe (Fig. 1A). Endoscopic evaluation of the
eft maxillary sinus showed tissue necrosis and the pathology
f the specimen was ‘chronic inﬂammation’. A careful scru-
inization of the chest CT conﬁrmed that there was no lesion
n the left lung at the initial presentation of the disease, and
review of the lung specimen taken from the right inferior
obe two years before showed anunknownbranchedpathogen
ith positive methenamine silver stain. Further, transtho-
acic lung biopsy exhibited inﬂammatory changes and sometissue (magniﬁcation,×40).
broad, non-septate hyphae with positive methenamine silver
stain, suggestive of pulmonary mucormycosis. A left inferior
lobectomy was performed with thoracoscopy. Histopatholog-
ical examination of the resected lung tissue showed broad,
irregularly branched and non-septate hyphae (Fig. 1B). Rhi-
zopus oryzae were identiﬁed in tissue specimen culture. A
diagnosis ofmucormycosis involving the left lung and sinuses
was therefore conﬁrmed. Surgical debridement of the sinuses
was undertaken, and amphotericin B therapy was initiated.
The patient was defervescent after the treatment, and the
erythrocyte sedimentation rate and C-reactive protein level
returned to normal. The boy was doing well during the follow-
up and was healthy on his last follow-up visit in September,
2011.
Discussion
Mucormycosis is an opportunistic infection that is very
rare in patients without predisposing risk factors. Superﬁ-
cial infections (such as cutaneous/subcutaneous infections)
are the most representative clinical manifestation.2 Deep
organ involvement is not common in immunocompetent indi-
viduals, while pulmonary mucormycosis is so rare that, to
the authors’ knowledge, only ten other cases of pulmonary
mucormycosis (excluding mucormycosis involving only the
mediastinum without either lung) in patients without under-
lying disease have been reported in the English language
literature3–12 since 1950 (Table 1). The present case not only
adds a further illustration of this rare medical condition, but
is also of interest for several reasons.
First, although the previously reported cases all included
patients without obvious underlying diseases, several poten-
tial risk factors might have still existed in some of them;
such as mild diabetes, broad-spectrum antibiotic treatment
after a fracture, etc.4,5 Moreover, almost all patients were
chronic smokers (ﬁve out of six after excluding those with-
out a clear history of smoking, and a two month old infant);7
and smoking, which may enhance the virulence of fungi13
and compromise the protective barriers14 in airways, has been
demonstrated to be a risk factor in fungal infection other than
mucormycosis.15 Furthermore, patients from most of the pre-
vious reports were of older age (mean age, 53 years; excluding
the infant), which often leads to a greater chance of having
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Table 1 – Reports of pulmonary mucormycosis in patients without underlying diseases.
No. Authors Gender Age (years) Smoking Farming Involvement Manifestation Treatment Follow-up after
disease onset
Prognosis
1 Murphy JD
et al.3
Male 40 Unknown Yes RML Nodule Surgery 3 months Alive
2 Blankenberg
HW et al.4
Female 23 Yes Unknown RML, RLL Abscess with
cavitation
Surgery 14 months Alive
3 Record NB
et al.5
Male 66 Yes Unknown LUL Abscess with
cavitation
Surgery+drug 4 months Deceased
4 Matsushima
T et al.6
Male 52 Yes Yes RUL Nodule Surgery 19 months Alive
5 Ferrinho P
Del GM7
Male 2 months — — Pneumia no 4 days Deceased
6 Lake FR
et al.8
Male 45 Unknown Unknown LUL Abscess with
cavitation
Surgery+drug 24 months Alive
7 Majid AA
et al.9
Male 66 Yes Yes LUL Nodule Surgery 8 months Alive
8 Kutsuzawa
T et al.10
Male 61 Unknown Yes RML, RLL, LUL Multiple
nodules
Drug 32 months Alive
9 Sharma A,
et al.11
Male 50 Yes Yes Multiple lobes Multiple
nodules
Drug 18 months Alive
10 Yokoi S
et al.12
Male 72 No Yes RLL Nodule Surgery 36 months Alive
11 Present Male 12 No Yes RLL, LLL Nodule Surgery+drug 5 years Alive
L, rigcase
RML, right middle lobe; RLL, right lower lobe; LUL, left upper lobe; RU
underlying conditions. One of the patients, for example, was
a 72-year-old male12 with a history of malaria and right clav-
icle and maxillary fracture. The present patient, at a much
younger age and with no history of smoking, may provide
more convincing evidence that a patient without any known
risk factors can be a victim of mucormycosis. This might
be due to the devastating nature of these ﬁlamentous fungi,
capable of secreting several toxins or proteases,16 which may
directly destroy endothelial cells in mucosal membranes and
cause subsequent deep organ infection.
Second, although surgery alone has been proved success-
ful in patients with pulmonarymucormycosis conﬁned to one
or two lobes,3,4,6,9,12 the present case showed that recurrent
infection might be a problem in post-operative patients with-
out continued treatment with anti-fungal drugs. To the best
of the authors’ knowledge, this is the only reported case of
an immunocompetent patient suffering from recurrent pul-
monary mucormycosis after lobectomy surgery. This might
be due to two possible reasons: ﬁrst, the longer follow-up of
the patient (ﬁve years after symptom onset and two years
after recurrence of infection) compared to other cases (mean
follow-up of 16months). There is a possibility that the patients
with surgical therapy alonemight have increased risk of recur-
rent mucormycosis if the follow-up period were extended.
The other potential reason might have been the concomitant
sinonasal involvement in this patient, as the sinus could serve
as a fungi ‘reservoir’ after pulmonary lobectomy that leads to
further recurrence. Therefore, the ﬁndings from the present
case suggest that surgery and antifungal therapy might be of
equal importance even for patients without underlying condi-
tions, and the sinonasal involvement could serve as apotential
risk factor for disease recurrence.Moreover, as the importance
of combination therapy consisting of surgery and antifun-
gal chemotherapy has been long recognized because it couldht lower lobe; RLL, right lower lobe; LLL, left lower lobe.
improve patients’ survival,1 this case also indicates that com-
bination therapy might prevent disease recurrence.
With a careful review of all the reported cases and the
present case, it was found that almost all patients farmed
at some time in their life, with the only exceptions being
the infant and those without reported occupational history.
This ﬁnding possibly reﬂects the fact that fungi in the order
of Mucorales often exist in decaying vegetation and in soils.
Thus, farming could be a predisposing risk factor and taking
a careful history might help.
Last but not the least, although cases of mucormycosis
without obvious risk factors have been reported inmany other
countries,2 no such cases have been reported in China, the
countrywith the largest population.2 Considering that the lan-
guage barrier could be a contributing factor, no such cases
were found in the Chinese language database CNKI (China
National Knowledge Infrastructure, the largest academic
database inChina). Thismight be due to theunder-recognition
of this disease in the immunocompetent population in China,
and in the present case, for example, the local hospital missed
the diagnosis. The authors thus hope that this present case
report can raise vigilance for the disease in China.
Conclusion
Pulmonary mucormycosis in the absence of underlying dis-
ease is a very rare clinical condition. The reported case of
a young male without history of smoking suggests that a
patient without any known risk factors could have pulmonary
mucormycosis. Surgical resection alone might be insufﬁcient
for eradication of pulmonary mucormycosis, even for local-
ized lesions, and recurrence of disease could ensue after
surgery. Antifungal therapy has proved to be beneﬁcial for
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atientoutcome. Farmingmight serve as a risk factor, and tak-
ng a careful history is warranted in suspicious cases.
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